Canaccord Genuity Maintains a 'Buy' on Meridian Biosciences (VIVO); Q3 Preview: Performing Well Despite Hurdles
Go back to Canaccord Genuity Maintains a 'Buy' on Meridian Biosciences (VIVO); Q3 Preview: Performing Well Despite Hurdles| ALERE, Inc. (NASDAQ: ALR) | Delayed: 1.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.32 | 52 Week High | $54.13 | |||
| Open | $10.12 | 52 Week Low | $31.47 | |||
| Day High | $1.32 | P/E | N/A | |||
| Day Low | $1.32 | EPS | $-1.13 | |||
| Volume | 7 | |||||
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 4.36 -0.04 (0.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.40 | 52 Week High | $21.49 | |||
| Open | $4.41 | 52 Week Low | $15.75 | |||
| Day High | $4.52 | P/E | 4.95 | |||
| Day Low | $4.21 | EPS | $0.88 | |||
| Volume | 273,180 | |||||

